Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3‐internal tandem duplication AML: The JALSG AML209‐FLT3‐SCT study

In this phase II multicenter study (JALSG AML209‐FLT3‐SCT), we aimed to prospectively elucidate the role of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) at first complete remission (CR1) for FLT3‐internal tandem duplication (ITD)‐positive AML. Newly diagnosed de novo AML patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawashima, Naomi, Ishikawa, Yuichi, Atsuta, Yoshiko, Sawa, Masashi, Ozawa, Yukiyasu, Hayashi, Masaki, Kohno, Akio, Tomita, Akihiro, Maeda, Tomoya, Sakaida, Emiko, Usuki, Kensuke, Hagihara, Maki, Kanamori, Heiwa, Matsuoka, Hiroshi, Kobayashi, Miki, Asou, Norio, Ohtake, Shigeki, Matsumura, Itaru, Miyazaki, Yasushi, Naoe, Tomoki, Kiyoi, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484840/
https://www.ncbi.nlm.nih.gov/pubmed/32391628
http://dx.doi.org/10.1111/cas.14448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484840/
https://www.ncbi.nlm.nih.gov/pubmed/32391628
http://dx.doi.org/10.1111/cas.14448

Ejemplares similares